SHORLA PHARMA
LIVE

Serial Number

88876368

Owner

Shorla Pharma Limited

Attorney

Sean P. McMahon

Filing Date

Apr 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SHORLA PHARMA Trademark

Serial Number: 88876368 • Registration: 6550083

SHORLA PHARMA is a trademark filed by Shorla Pharma Limited on April 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Shorla Pharma Limited (11 trademarks)

Questum Acceleration Centre
Clonmel, Co. Tipperary E91V239 , IE

Entity Type: 99

Trademark Details

Filing Date

April 17, 2020

Registration Date

November 9, 2021

Published for Opposition

August 24, 2021

Goods & Services

pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumors; anti-cancer drugs and pharmaceutical preparations

research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 25, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 24, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 24, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 4, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 19, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2021 CRFA
ASSIGNED TO LIE
Jun 7, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Mar 12, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2021 TROA
PETITION TO REVIVE-GRANTED
Mar 11, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Mar 11, 2021 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 11, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 11, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 28, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2020 NWOS
NEW APPLICATION ENTERED
Apr 21, 2020 NWAP